Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/27/2935974/0/en/ENA-Respiratory-Progresses-Phase-Ib-Study-of-its-Dry-Powder-Formulation-of-Intranasal-Innate-Immunomodulator-INNA-051.html
https://www.globenewswire.com/news-release/2024/05/08/2877495/0/en/ENA-Respiratory-Receives-USPTO-Notice-of-Allowance-for-Key-Patent-Covering-INNA-051-a-First-in-Class-Antiviral-Innate-Immunomodulator.html
https://www.globenewswire.com/news-release/2024/04/29/2870969/0/en/ENA-Respiratory-Announces-FDA-IND-Clearance-for-its-Prophylactic-Intranasal-INNA-051-a-First-in-Class-Antiviral-Innate-Immunomodulator.html
https://www.globenewswire.com//news-release/2023/08/29/2733348/0/en/ENA-Respiratory-Expands-Leadership-Team-and-Extends-U-S-Department-of-Defense-Funding-to-Enable-Phase-II-Program-of-INNA-051-in-Community-Acquired-Viral-Respiratory-Infections.html
https://www.fiercebiotech.com/biotech/ena-slices-data-claim-flu-success-phase-2-trial-wide-ranging-nasal-spray
https://www.fiercepharma.com/pharma/jj-program-adds-enas-infectious-disease-nasal-spray-roster
https://www.globenewswire.com/news-release/2022/05/11/2440777/0/en/ENA-Respiratory-Selected-for-BLUE-KNIGHT-to-Accelerate-Development-of-Pan-Antiviral-Nasal-Spray.html
https://www.globenewswire.com/news-release/2021/09/28/2304369/0/en/First-in-Class-Broad-Spectrum-Nasal-Spray-to-Prevent-COVID-19-and-Other-Common-Respiratory-Illnesses-Set-to-Begin-Phase-2-Trials.html
https://www.globenewswire.com/news-release/2021/07/13/2261910/0/en/ENA-Respiratory-Begins-Phase-I-Study-of-COVID-19-Preventative-Nasal-Spray-Designed-to-Stimulate-Body-s-Firstline-Immune-Defense-in-the-Nose.html